Glucagon Emergency Kit for Low Blood Sugar — Class I drug recall D-0009-2022
Terminated recall by Eli Lilly & Company, reported 2021-10-20, distributed nationwide. SUBPOTENT DRUG: Vial contained a liquid substance, instead of the expected powder substance. There was also a
| Recall number | D-0009-2022 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Eli Lilly & Company, Indianapolis, IN, United States |
| Recall initiated | 2021-09-24 |
| Classified | 2021-10-14 |
| Reported by FDA | 2021-10-20 |
| Terminated | 2024-09-06 |
| Distributed | Nationwide (US) |
| Countries outside the US | AR, CA, CR, MX |
| Quantity | 19,174 syringes |
| Reason classes | potency |
| NDC | 00002-8031-01 |
| Lot numbers | D239382D |
| Expiration dates | 2022-04-20 |
Product
Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection, 1 mg per vial; Diluent for Glucagon, 1 mL syringe. Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285; Glucagon, NDC: 0002-8031-01
Reason for recall
SUBPOTENT DRUG: Vial contained a liquid substance, instead of the expected powder substance. There was also a lack of full drug effect upon administration.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0009-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.